Page last updated: 2024-09-02

fingolimod hydrochloride and Cholangiocarcinoma

fingolimod hydrochloride has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, H; Liang, Y; Liu, L; Lu, Z; Pan, S; Pei, T; Song, R; Wang, J; Yin, D; Zheng, T	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Cholangiocarcinoma

Article	Year
FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. BMC cancer, 2014, Oct-25, Volume: 14 Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Phosphorylation; Propylene Glycols; Signal Transduction; Sphingosine; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays	2014

Article

Year

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.

BMC cancer, 2014, Oct-25, Volume: 14

Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Phosphorylation; Propylene Glycols; Signal Transduction; Sphingosine; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays

2014